AstroNova, Inc. Files 8-K for Material Agreement

TL;DR

AstroNova signed a big deal on 10/31, filing it 11/6. Details in the exhibits.

AI Summary

On October 31, 2025, AstroNova, Inc. entered into a material definitive agreement, likely related to a direct financial obligation or an off-balance sheet arrangement. The filing also includes financial statements and exhibits, with the report being filed on November 6, 2025.

Why It Matters

This filing indicates a significant new financial commitment or arrangement for AstroNova, Inc., which could impact its financial obligations and future operations.

Risk Assessment

Risk Level: medium — Material definitive agreements and financial obligations can introduce new risks or alter existing ones for a company.

Key Players & Entities

• AstroNova, Inc. (company) — Registrant
• October 31, 2025 (date) — Date of earliest event reported
• November 6, 2025 (date) — Filing date
• 600 East Greenwich Avenue West Warwick, RI 02893 (address) — Principal executive office address

FAQ

Key Financial Figures

• $0.05 — nge on which Registered Common Stock, $0.05 Par Value ALOT NASDAQ Global Market
• $25,000,000 — volving loan commitment thereunder from $25,000,000 to $27,500,000 until July 31, 2026, aft
• $27,500,000 — mmitment thereunder from $25,000,000 to $27,500,000 until July 31, 2026, after which the ag
• $10,000,000 — ew term loan in the principal amount of $10,000,000 (the "Term Loan") and a new term A-2 lo
• $9,720,000 — erm A-2 loan in the principal amount of $9,720,000 (the "Term A-2 Loan"). At the closing o
• $1,500,000 — the entire $9,720,000 Term A-2 Loan and $1,500,000 under the revolving credit facility. Th
• $17.9 million — ate purposes. The Company currently has $17.9 million drawn on the amended revolver. Under
• $500,000 — ly 31, 2028, in the principal amount of $500,000 each, and the entire then-remaining pri
• $40,500 — ly 31, 2035, in the principal amount of $40,500 each, and the entire then-remaining pri

Filing Documents

• d32176d8k.htm (8-K) — 37KB
• d32176dex101.htm (EX-10.1) — 842KB
• 0001193125-25-269982.txt ( ) — 1182KB
• alot-20251031.xsd (EX-101.SCH) — 3KB
• alot-20251031_lab.xml (EX-101.LAB) — 17KB
• alot-20251031_pre.xml (EX-101.PRE) — 11KB
• d32176d8k_htm.xml (XML) — 3KB

From the Filing

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 31, 2025 ASTRONOVA, INC. (Exact name of registrant as specified in its charter) Rhode Island 0-13200 05-0318215 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 600 East Greenwich Avenue West Warwick , RI 02893 (Address of principal executive offices) (Zip Code) (401) 828-4000 Registrant's telephone number, including area code Not applicable (Former name or former address, if changed since last report.) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of Each Class Trading Symbol(s) Name of Each Exchange on which Registered Common Stock, $0.05 Par Value ALOT NASDAQ Global Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item1.01 Entry into a Material Definitive Agreement The information set forth in Item 2.03 below is incorporated herein by reference. Item2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. On October 31, 2025, AstroNova, Inc. (the "Company") entered into a Sixth Amendment to Amended and Restated Credit Agreement (the "Amendment") with Bank of America, N.A., as lender (the "Lender"). The Amendment amended the Amended and Restated Credit Agreement dated as of July 30, 2020, as amended by the First Amendment to Credit Agreement, dated as of March 24, 2021, the LIBOR Transition Amendment, dated as of December 14, 2021, the Second Amendment to Amended and Restated Credit Agreement dated as of August 4, 2022, the Joinder Agreement relating to the Company's subsidiary Astro Machine Corporation ("Astro Machine") dated as of August 26, 2022, the Third Amendment to Amended and Restated Credit Agreement dated as of May 6, 2024, the Fourth Amendment to Amended and Restated Credit Agreement dated as of March 20, 2025, and the Fifth Amendment to Amended and Restated Credit Agreement and Waiver Agreement dated as of September 8, 2025 (the "Existing Credit Agreement"; the Existing Credit Agreement as amended by the Amendment, the "Amended Credit Agreement"), among the Company as borrower, Astro Machine as a guarantor, and the Lender. The Amended Credit Agreement provides for, among other modifications of the Existing Credit Agreement, (i) an increase in the aggregate principal amount of the revolving loan commitment thereunder from $25,000,000 to $27,500,000 until July 31, 2026, after which the aggregate principal amount of the revolving credit facility will reduce to $25,000,000; (ii) an extension of the maturity date of the revolving loan facility thereunder from August 4, 2027 to August 4, 2028; and (iii) the refinancing of the existing term loans under the Existing Credit Agreement into a new term loan in the principal amount of $10,000,000 (the "Term Loan") and a new term A-2 loan in the principal amount of $9,720,000 (the "Term A-2 Loan"). At the closing of the Amendment, the Company borrowed the entire $10,000,000 Term Loan, the entire $9,720,000 Term A-2 Loan and $1,500,000 under the revolving credit facility. The proceeds of such borrowings were used primarily to repay and refinance the existing term loans together and to pay certain related transaction costs. The revolving credit facility may otherwise be used for general corporate purposes. The Company currently has $17.9 million drawn on the amended revolver. Under the Amended Credit Agreement, revolving credit loans may continue to be borrowed, at the Company's option, in U.S. Dollars or, subject to certain conditions, Euros, British Pounds, Canadian Dollars or Danish Kroner. The Amended Credit Agreement requires that the Term Loan be paid in quarterly installments

View Full Filing

View this 8-K filing on SEC EDGAR